Mediacenter
Interactive & Videos
Play Video
Play Video
Play Video
7th International CytoSorb Users` Meeting | 2020
1/17 videos
1
Welcome | Stefan Baudis & Christian Steiner | 7th International CytoSorb Users` Meeting | 2020
12:37
2
The Rotterdam study – long term outcome in septic shock patients | Can Ince | 7th IUM | 2020
11:12
3
Impact on hemodynamics and shock reversal – we observe it | Konstanty Szuldrzynski | 7th IUM | 2020
09:08
4
The International CytoSorb Registry | Frank Brunkhorst | 7th International CytoSorb Users` Meeting |
15:23
5
The CytoScore – a new tool to optimize the starting point | Klaus Kogelmann | 7th IUM | 2020
13:16
6
Liver support on a higher level – what we already know | Mihai Popescu | 7th IUM | 2020
10:34
7
The right anticoagulation – we have a lot of options | Gilda Cinnella | 7th IUM | Berlin | 2020
20:17
8
Update on drug removal – more pros than cons | Steffen Mitzner | 7th IUM | Berlin | 2020
15:09
9
Rationale for the use of CytoSorb in COVID-19 patients | Axel Nierhaus | 7th IUM | Berlin | 2020
21:27
10
Experiences from Italy | Giorgio Berlot | 7th International CytoSorb Users` Meeting | Berlin | 2020
12:21
11
Experiences from Iran | Amir Ahmad Nassiri | 7th International CytoSorb Users` Meeting | 2020
17:01
12
Experiences from the US | Michael Firstenberg | 7th International CytoSorb Users` Meeting | 2020
12:18
13
Experiences from Latin America | José Ernesto López Almaraz | 7th IUM | Berlin | 2020
14:59
14
Complex case of TTP associated with severe pancreatitis | Stephan Ziegeler | 7th IUM | Berlin | 2020
09:21
15
Cytokine release syndrome after CAR-T-Cell therapy | Gabriella Bottari | 7th IUM | Berlin | 2020
08:37
16
MDMA intoxication | Alexander Supady | 7th International CytoSorb Users` Meeting | Berlin | 2020
06:40
17
Closing remarks | Efthymios Deliargyris | 7th International CytoSorb Users` Meeting | Berlin | 2020
10:35
EACTS | 2020
1/5 videos
1
CytoSorbents Introduction | EACTS 2020
02:34
2
Mitral valve endocarditis – new chances to improve the outcome | Daniel Wendt | EACTS 2020
21:13
3
Aortic surgery – modulation of the inflammatory response | Yatin Mehta | EACTS 2020
10:40
4
Removal of Ticagrelor during emergency heart surgery | Stephan Geidel | EACTS 2020
19:48
5
Successful treatment of rhabdomyolysis following heart transplantation | Udo Boeken | EACTS 2020
12:20
CytoSorb Liver Playlist | 2020
1/2 videos
1
New liver support theraphy | Ivano Riva | e-ISICEM 2020
07:36
2
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
CytoSorb Liver Playlist | Spanish subtitle | 2020
1/2 videos
1
New liver support theraphy | Ivano Riva | e-ISICEM 2020 | spanish subtitle
07:36
2
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
21:27
CytoSorb Therapy Enhanced ECMO | Clinical Compendium
1/15 videos
1
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
30:04
2
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
01:27:59
3
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
01:13:57
4
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
01:29:34
5
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
6
CytoSorb ECMO Integration - English - Animation
03:35
7
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
8
CytoSorb integration with ECMO-Guidance with animated Video
03:36
9
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
10
Integration of CytoSorb with ECMO Therapy extends your therapeutic options Full HD
17:55
11
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
12
ECMO plus CytoSorb | DIVI | 2019 | Hamburg
13:56
13
CytoSorb und ECMO - Erfahrungen aus Freiburg | Alexander Supady
17:06
14
CytoSorb und ECMO - Erfahrungen aus Ibbenbüren | Stephan Ziegeler
13:46
15
COVID 19 NUEVAS TENDENCIAS EN ECMO
02:15:51
Joint Perfusion COVID-19 Task Force
1/3 videos
1
Joint Perfusion COVID-19 Task Force Webinar: Rationale and Practical use of CytoSorb
01:31:26
2
Joint Perfusion COVID-19 Task Force: COVID-19 Patient Transport and Cytosorb Use
01:13:57
3
Joint Perfusion COVID-19 Task Force: COVID-19 In Practice Third Webinar
01:01:52
COVID-19 and CytoSorb Therapy | Webinar
1/4 videos
1
Webinar | EuroELSO 2020 Virtual ECMO Day | June 25, 2020
30:04
2
Webinar | The trinity of COVID-19: Immunity, Inflammation and Intervention | May 20th 2020
01:27:59
3
Webinar | Cytokine adsorption in severely ill COVID-19 patients | April 16th 2020
01:29:34
4
Webinar | CytoSorb therapy in COVID-19 patients
27:58
EACTS | 2019 | Lisbon | Symposium
1/17 videos
1
Enhanced hemodynamic and metabolic stability in aortic surgery | EACTS | 2019 | Lisbon |
14:20
2
Improved clinical outcome in ECMO patients | EACTS | 2019 | Lisbon |
18:29
3
Intraoperative use in endocarditis -The REMOVE trial | EACTS | 2019 | Lisbon |
17:20
4
Faster control of refractory vasoplegic shock | Nandor Marczin | EACTS 2019
22:45
5
6
Effects on outcome in mitral valve infective endocarditis | Daniel Wendt | EACTS 2019
15:26
7
Reduction of inflammation in heart transplantation | Endre Németh | EACTS | 2019 | Lisbon
17:27
8
Removal of Ticagrelor | Stephan Geidel | EACTS 2019
20:12
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019
13:22
10
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
11
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
12
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
13
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
14
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Polish Subtitles
13:22
15
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
16
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
17
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
EACTS | 2019 | Lisbon | Symposium with subtitles
1/9 videos
1
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | French Subtitles
15:30
2
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | German Subtitles
15:32
3
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Italian Subtitles
15:30
4
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Polish Subtitles
15:30
5
Removal of Ticagrelor | Stephan Geidel | EACTS 2019 | Spanish Subtitles
15:32
6
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | French Subtitles
13:22
7
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Italian Subtitles
13:22
8
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | German Subtitles
13:22
9
The emergency surgical patient under Ticagrelor | Pascale Leprince | EACTS 2019 | Spanish Subtitles
13:22
ESICM Lives 2019 | Berlin
1/7 videos
1
Improved outcome of patients in septic shock | ESICM Lives 2019: Webcast
24:20
2
3
What makes it unique Rationale of CytoSorb | ESICM Lives 2019: Webcast
20:10
4
Drug removal and safety aspects – what do we currently know | ESICM Lives 2019: Webcast
18:01
5
Improved outcome of patients in septic shock | ESICM Lives 2019: Summary
01:53
6
Advantages of CytoSorb compared to other liver support systems | ESICM Lives 2019: Webcast
21:27
7
Jan Stange y Advantages compared to other liver support systems | ESICM Lives 2019: Webcast | SPA
21:27
Sepsis Update 2019 | Weimar | Symposium Webcast
1/4 videos
1
Hemodynamic changes during hemoadsorption – Which parameters matter | Sepsis Update 2019
18:06
2
Timing and dosing as part of an individualized therapy in septic shock | Sepsis Update 2019
16:04
3
How we use CytoSorb in clinical routine | Sepsis Update 2019
11:24
4
What makes it unique? Rationale and background of CytoSorb Therapy | Sepsis Update 2019
14:22
TCS ECMO 2019 | Paris | Symposium Webcast
1/2 videos
1
TCS ECMO 2019 | Paris | Webcast Pappalardo
11:53
2
TCS ECMO 2019 | Paris | Webcast Traeger
27:23
6th International CytoSorb Users` Meeting | 2019 | Brussels
1/10 videos
1
Welcome - 6th International CytoSorb Users` Meeting
09:06
2
My very special CytoSorb case
11:16
3
My clinical experiences after 100 patients
11:48
4
From experiments to evidence: Safety aspects and drug removal
46:58
5
Hemoadsorption modulates pulmonary metabolism and edema formation
11:56
6
CytoSorb in cardiac arrest
11:08
7
CytoScore helps me to find the right starting point
10:26
8
Opening Lecture: Past, present and future of CytoSorb
30:36
9
CytoSorb in various fields of application: Liver failure
15:04
10
What do we know and what do we have to do? CytoSorb in various fields of application: ECMO
11:34
EACTS | 2018 | Milan | Symposium Webcast
1/5 videos
1
MOF in ECMO patients and the impact of CytoSorb therapy – 3 years’ experience
09:19
2
Improved outcome of patients undergoing heart transplant with CytoSorb | EACTS | 2018 | Milan
09:34
3
Clinical effects of intraoperative hemoadsorption in acute infective endocarditis – A case series
10:57
4
5
Intraoperative removal of Ticagrelor to reduce bleeding complications... | EACTS | 2018 | Milan
09:13
Application of Cytosorb
1/6 videos
1
Hemoperfusion set up for stand alone application of CytoSorb
02:09
2
CytoSorb ECMO Integration - English - Animation
03:35
3
CTSO Application PreDialzer
02:57
4
CTSO Application PostDialzer
03:09
5
CTSO Application CPB
02:33
6
CTSO Application exchange
02:16
CytoSorb Testimonials
1/6 videos
1
Future – What do you think about the future of CytoSorb?
01:56
2
Early use – When should CytoSorb be started in septic shock?
01:15
3
Safety – How would you describe the safety profile of CytoSorb?
46
4
Ease of use – How easy is the set-up of CytoSorb?
01:05
5
Clinical effects – What are the most impressive clinical effects when you use CytoSorb?
04:37
6
CytoSorb Testimonials
03:30
Disclaimer
The statements here represent the personal opinions and views of the speaker only and do not necessarily reflect accepted medical knowledge in general or indications covered by the intended use of CytoSorb. CytoSorb must be used by health care professionals only.
